title: The nanomedicine revolution: part 3: regulatory and safety challenges.
abstract: Before the FDA can set up safety guidelines for nanomedicines, it needs to establish valid testing criteria. The goal is to strike a balance between underregulation (which can lead to questionable approvals) and overregulation (which can inhibit innovation).
authors.forename: C Lee
authors.initials: CL
authors.lastname: Ventola